NCT00510536View on ClinicalTrials.gov

Treatment of Mild to Moderate Joint Pain in Patients With Chronic Plaque Psoriasis Receiving Efalizumab

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
ArthritisArthralgia
Interventions
DRUG

Acetaminophen

dose to be determined by investigator

DRUG

NSAID

dose to be determined by investigator

Trial Locations (1)

N2J 1C4

K. Papp Clinical Research Inc., Waterloo

Sponsors
All Listed Sponsors
lead

Probity Medical Research

NETWORK

NCT00510536 - Treatment of Mild to Moderate Joint Pain in Patients With Chronic Plaque Psoriasis Receiving Efalizumab | Biotech Hunter | Biotech Hunter